Chemicals & Advanced Materials Global On demand · 24-48h

Global 5-Nitroisophthalic Acid Market Strategic Research Report

Global 5-Nitroisophthalic Acid Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global 5-Nitroisophthalic Acid Market
$28.762025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Purity 98%, Purity 99%, Others

By Application: Contrast Media Intermediates, Specialty Polymers and Coatings, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Blue Jet Healthcare, Arvee Laboratories, Elppe, Jay Finechem, Shubham Specialty Products, Sarna Chemicals, Prism Industries, Synthesia, Jiangxi Dayu Pharmaceutical, Gansu Shengnuo Pharmaceutical Technology, Guangxi Shengtai Chemical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 125 pages
Market size 2025
$28.76
Million USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$41.8
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global 5-Nitroisophthalic Acid market size is predicted to grow from US$ 28.76 million in 2025 to US$ 42.35 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

5-Nitroisophthalic acid is a nitro-substituted aromatic dicarboxylic acid with the molecular formula C8H5NO6 and CAS number 618-88-2. It is generally supplied as a white to pale-yellow crystalline powder, with major non-reagent products comprising industrial grades with purity of 98.0%-<99.0% and pharmaceutical-intermediate grades with purity ≥99.0%. It is typically produced from isophthalic acid through mixed-acid nitration, crystallization, filtration, washing, and drying. Key upstream inputs include isophthalic acid, nitric acid, sulfuric acid, alkaline neutralizing agents, utilities, and packaging materials, while major downstream customers include manufacturers of iodinated contrast-media intermediates and APIs, pharmaceutical-intermediate and custom-synthesis companies, and a smaller number of specialty polymer, coating, and fine-chemical producers. Based on non-reagent products measured at producer ex-factory prices, global effective nameplate capacity in 2025 is estimated at approximately 5,600 metric tons, with actual sales volume of about 3,846 metric tons, an average ex-factory price of approximately USD 7.65 per kilogram, and typical producer gross margins of approximately 26%-37%.

The global 5-nitroisophthalic acid market is characterized by a high degree of specialization and regional concentration, with most non-reagent industrial capacity located in China and India and only a limited number of established producers remaining in Europe. Market participants are generally pharmaceutical-intermediate, iodinated contrast-media intermediate, or custom-chemical manufacturers, while relatively few companies treat the product as a standalone core business. Production is commonly carried out in multipurpose nitration facilities or integrated with downstream esterification and reduction processes. Competition is determined not only by price but also by impurity control, batch consistency, process safety, environmental compliance, and customer-audit capabilities, giving qualified producers with stable pharmaceutical customer relationships a stronger position.

Non-ionic iodinated contrast media remain the principal source of demand. 5-Nitroisophthalic acid is further converted into dimethyl 5-nitroisophthalate, 5-aminoisophthalic acid, and more advanced intermediates used in the contrast-media value chain. Growth in diagnostic imaging procedures, expansion of the installed base of CT equipment, population ageing, and improving healthcare access in emerging markets will continue to support demand for related intermediates. Applications in specialty polymers, coatings, dyes, and other fine chemicals provide additional consumption, but their combined contribution remains limited and is unlikely to alter the dominant position of pharmaceutical and diagnostic-imaging applications.

Manufacturing development will increasingly focus on nitration safety, mixed-acid recycling, low-temperature heat transfer, automated feed control, mother-liquor recovery, and the reduction of waste acid and wastewater. Conventional batch mixed-acid nitration is technically mature and operationally flexible, but it involves concentrated heat release, relatively high acid consumption, and substantial environmental-treatment requirements. Automated process control and continuous nitration can improve reaction stability and reduce unwanted by-products. Producers are also expected to expand further into esterification, reduction, and advanced contrast-media intermediates in order to capture higher value, share manufacturing infrastructure, and reduce exposure to price volatility in the base intermediate.

The market is expected to maintain steady growth, although expansion will continue to be constrained by environmental and safety expenditure, lengthy customer-qualification cycles, concentrated downstream demand, and captive production by integrated manufacturers. Large contrast-media API and intermediate producers may secure supply through long-term purchasing agreements, custom manufacturing, or internal integration, causing the merchant market to grow more slowly than final contrast-media demand. At the same time, pharmaceutical customers will continue to tighten requirements for traceability, impurity profiles, and supply continuity. Smaller suppliers lacking compliant facilities and stable quality-management systems will face increasing pressure, and the global supply structure is likely to gradually concentrate among producers with greater scale, stronger compliance, and multistep intermediate capabilities.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 5-Nitroisophthalic Acid market?

What factors are driving 5-Nitroisophthalic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 5-Nitroisophthalic Acid market opportunities vary by end market size?

How does 5-Nitroisophthalic Acid break out by Type, by Application?

This report presents a comprehensive overview of the global 5-Nitroisophthalic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Purity 98%
  • Purity 99%
  • Others

Segment by Product Grade

  • Industrial Grade
  • Pharmaceutical Grade
  • Others

Segment by Downstream Conversion Route

  • Esterification
  • Reduction
  • Direct Use
  • Others

Segment by Application

  • Contrast Media Intermediates
  • Specialty Polymers and Coatings
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 5-Nitroisophthalic Acid market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Contrast Media Intermediates, Specialty Polymers and Coatings, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global 5-Nitroisophthalic Acid Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$28.76
2025
Forecast
$41.8
2032
CAGR
5.5%
2025–2032
Regions
5
global
Key companies
Blue Jet HealthcareArvee LaboratoriesElppeJay FinechemShubham Specialty ProductsSarna ChemicalsPrism IndustriesSynthesia
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Purity 98%Purity 99%Others
By Application
Contrast Media IntermediatesSpecialty Polymers and CoatingsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Purity 98%
  • 3.1.3 Purity 99%
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Contrast Media Intermediates
  • 4.1.3 Specialty Polymers and Coatings
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Blue Jet Healthcare
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Arvee Laboratories
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Elppe
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Jay Finechem
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Shubham Specialty Products
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sarna Chemicals
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Prism Industries
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Synthesia
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Jiangxi Dayu Pharmaceutical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Gansu Shengnuo Pharmaceutical Technology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Guangxi Shengtai Chemical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global 5-Nitroisophthalic Acid market?
The global 5-Nitroisophthalic Acid market is estimated at US$ 28.76 million in 2025 (base year) and is projected to reach US$ 42.35 million by 2032.
How fast is the 5-Nitroisophthalic Acid market expected to grow?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 28.76 million in 2025 to US$ 42.35 million in 2032, roughly 1.5 times its base-year value.
What does the 5-Nitroisophthalic Acid market cover?
5-Nitroisophthalic acid is a nitro-substituted aromatic dicarboxylic acid with the molecular formula C8H5NO6 and CAS number 618-88-2. It is generally supplied as a white to pale-yellow crystalline powder, with major non-reagent products comprising industrial grades with purity of 98.0%-<99.0% and pharmaceutical-intermediate grades with purity ≥99.0%. It is typically produced from isophthalic acid through mixed-acid nitration, crystallization, filtration, washing, and drying.
How is the 5-Nitroisophthalic Acid market segmented by type?
By type, the market is segmented into Purity 98%, Purity 99% and Others.
What are the key applications of 5-Nitroisophthalic Acid?
Key applications covered include Contrast Media Intermediates, Specialty Polymers and Coatings and Other.
Which companies are profiled in the 5-Nitroisophthalic Acid market report?
Key players profiled include Blue Jet Healthcare, Arvee Laboratories, Elppe, Jay Finechem, Shubham Specialty Products, Sarna Chemicals, Prism Industries and Synthesia, among 11 companies covered in total.
What geographies does the 5-Nitroisophthalic Acid market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for 5-Nitroisophthalic Acid?
What factors are driving 5-Nitroisophthalic Acid market growth, globally and by region?
What are the main risks and barriers in the 5-Nitroisophthalic Acid market?
Producers are also expected to expand further into esterification, reduction, and advanced contrast-media intermediates in order to capture higher value, share manufacturing infrastructure, and reduce exposure to price volatility in the base intermediate.
Who should buy the 5-Nitroisophthalic Acid market report?
The report is intended for manufacturers and solution providers, distributors and end users in Contrast Media Intermediates, Specialty Polymers and Coatings and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the 5-Nitroisophthalic Acid market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.